A new UC Davis-led study sheds light on cell type-specific biomarkers, or signs, of melanoma. The research was recently published in the Journal of Investigative Dermatology.
Health Professionals
In Recent Decades, Immunotherapy Extended Advanced Melanoma Survival from Months to Years
Thanks to the advent of immunotherapy, average survival for patients with advanced melanoma is drastically better than it was decades ago, explained Dr. Jedd D. Wolchok, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.
Genetic Patterns, Targeted Therapy Resistance Link in Melanoma Explored in New Study
The analysis could help investigators better understand why a subset of patients with advanced melanoma develops resistance or does not respond to targeted therapy.
Amazon launches cancer vaccine clinical trial in partnership with Fred Hutchinson
Amazon is developing cancer vaccines in collaboration with the Fred Hutchinson Cancer Research Center, and it recently launched an FDA-approved clinical trial.